AI assistant
Sending…
C4 Therapeutics, Inc. — Director's Dealing 2020
Oct 2, 2020
33861_dirs_2020-10-01_31c5181a-a101-4508-92aa-5117decbff58.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: C4 Therapeutics, Inc. (CCCC)
CIK: 0001662579
Period of Report: 2020-10-01
Reporting Person: Hirsch Andrew (Director, See Remarks)
More from C4 Therapeutics, Inc.
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Board/Management Information
2026
Apr 10
Capital/Financing Update
2026
Apr 9
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Director's Dealing
2026
Feb 18